FORA

Forian Inc
CAPPED RATING

Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.

Forian Inc (FORA) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Growth (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
C+
Factor Score 2.7 / 5.0
Growth
D
Factor Score 1.2 / 5.0
Profitability
C+
Factor Score 2.6 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 20.1
Rev Growth YoY -2.9%
Gross Margin 47.2%
Price Return 3M 17.2%
Price Return 12M 29.9%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 2.3
ROE -17.9%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C+ (2.7) D (1.2) C+ (2.6) C (2.4) C- (1.9) C (2.2)
2026-08-04 C+ (2.7) D (1.2) C+ (2.6) C (2.4) C- (1.9) C (2.2)
2026-08-03 C+ (2.7) C- (2.0) B- (2.9) C (2.4) C- (2.0) C (2.4)
2026-08-02 C+ (2.7) C- (2.0) C+ (2.8) C (2.4) C- (1.9) C (2.4)